On January 1, the departments of Clinical research and Pharmaceutical sciences merged into a single department called Department of Pharmaceutical and Clinical Sciences (PCS). Dr. Charles A. Carter served as interim president, helping to initiate and lead the initial transition phase.
On July 1, he was named the department’s new director.
In its letter of recommendation to Dean Michael L. Adams, the search committee noted the energy, vision, and positivity that Carter brought to his work leading the department and the College. “Committee members said his work over the past six months as a temp in the newly created department was a ‘much higher threshold than an interview,'” Adams concluded.
A native of Kenmore, New York, Carter moved to North Carolina in 1996. He earned his Bachelor of Science degree from Buffalo State University of New York, a Doctor of Pharmacy degree from the Health Sciences Center of the University of Tennessee and an MBA from Christian Brothers University. . He also completed a residency in bioinformatics and drug information and a fellowship in research design methodology.
“Dr. Carter embodies the mission and spirit of Campbell University.
Carter joined the Campbell University family in August 2015. His initial appointment was as Associate Professor at the Clinical Research Department. He has taught in the Bachelor of Science in Clinical Research (BSCR), Master of Science in Clinical Research (MSCR), Doctor of Pharmacy (PharmD) study programs, as well as Interprofessional education courses and internships. In addition to her teaching responsibilities, Carter mentors and advises students on their educational and post-graduate journeys. He also advises student-run organizations on campus, including the Graduate Clinical Research Organization (GCRO), the Industry Pharmacists Association (IPHO), and the Kappa Psi Pharmaceutical Fraternity.
Before joining the College of Pharmacy and Health Sciences (CPHS), Carter served as Executive Director of Medical Affairs for Salix Pharmaceuticals, Inc. in Raleigh, North Carolina from 2012 to 2015. From 1994 to 2012, he founded and operated Pharmaceutical Strategic Initiatives, LLC and focused his energies on the company vision and services. . Pharmaceutical Strategic Initiatives was a leading provider of strategic consulting, clinical research design and strategy, regulatory readiness, medical and scientific content creation, health outcomes research, key opinion leader and advocacy development. Strategic Pharmaceutical Initiatives clients included 28 pharmaceutical and medical device companies.
Carter was previously director of research and clinical services at the National Institute of Drug Therapy located in Memphis, Tennessee. He has been an investigator in over 30 Phase 3, Phase 4, and health economics and outcome research studies.
Dr. Scott Asbill, Associate Dean of Academic Affairs, Professor of Pharmacy and Senior Member of the President’s Search Committee, shared: “Dr. Carter embodies the mission and spirit of Campbell University. He served as interim president for about six months and did a tremendous job moving the department forward.
Carter possesses a servant attitude and aspires to demonstrate it to those he meets. When asked why he accepted the position of president, he replied, “I feel called to serve, so I serve. Carter enjoys working at Campbell and is excited about his new responsibilities and the merging of departments.